Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Return on Equity (2022 - 2026)

Envoy Medical's Return on Equity history spans 5 years, with the latest figure at 0.24% for Q1 2026.

  • On a quarterly basis, Return on Equity rose 23.0% to 0.24% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.24%, a 23.0% increase, with the full-year FY2025 number at 0.02%, changed 0.0% from a year prior.
  • Return on Equity hit 0.24% in Q1 2026 for Envoy Medical, up from 0.02% in the prior quarter.
  • Over the last five years, Return on Equity for COCH hit a ceiling of 0.24% in Q1 2026 and a floor of 0.07% in Q4 2023.
  • Historically, Return on Equity has averaged 0.02% across 5 years, with a median of 0.01% in 2025.
  • Biggest five-year swings in Return on Equity: dropped -6bps in 2023 and later rose 23bps in 2026.
  • Tracing COCH's Return on Equity over 5 years: stood at 0.01% in 2022, then crashed by -1004bps to 0.07% in 2023, then soared by 115bps to 0.01% in 2024, then surged by 124bps to 0.02% in 2025, then surged by 907bps to 0.24% in 2026.
  • Business Quant data shows Return on Equity for COCH at 0.24% in Q1 2026, 0.02% in Q4 2025, and 0.01% in Q3 2025.